How MNT works —
and how it’s different

Custom-built, dynamic patient audiences based on brand eligibility signals for hyperlocal, real-time targeting. 

In today’s world of increasingly scrutinized consumer targeting practices, ballooning marketing costs, and ‘black box’ measurement practices, our patented Micro-Neighborhood® Targeting MNT technology is trusted by over 150 pharmaceutical brands to reach the right patients while addressing current and emerging state regulations.   

MNT is just what it sounds like: a way to find and engage your patients with an unparalleled level of clinical precision in hyper-local clusters. As part of the Dynamic Audience Activation Platform (DAAP), MNT now incorporates AI to detect potential brand eligibility within the U.S. population, for the most timely and inclusive targeting approach possible. 

Micro-Neighborhood® Targeting at a Glance

Reach and engage more of your ideal patient audiences during key care windows, regardless of where they live or their preferred media - including often underserved areas. 

Building a robust clinical and behavioral patient profile for brand eligibility

We utilize real-world medical evidence including a vast warehouse of open and closed medical claims, commercial and specialty prescription claims, as well an array of consumer attributes and social determinants of health to identify the key signals of brand eligibility and build a brand-specific AI predictive model. 

Privacy-safe prioritization of hyperlocal geographies based on a concentration of brand eligibility signals

MNT looks for all patients expressing brand eligibility signals (covering more than 90% of the U.S. population) then scores over 35 million zip-9 geographies based on the concentration of those signals to create a prioritized, highly specific, and privacy-safe audience. Geographies are automatically refreshed and prioritized constantly for maximum marketing relevance and precision. 

Maximized patient reach through ongoing, conversion-focused optimization

Unlike static audiences where lower-volume geographics may be cut due to budget constraints, dynamic audience reprioritization provides nationwide scale – focused on reaching each patient during conversion opportunity windows, so each marketing dollar delivers more commercial impact. 

Exceptional Patient Specificity  Without Privacy Concerns

What Are Your Top Needs?   Let’s Start There.

We’re here to help you capitalize on the latest marketing science. Our patient-centric, patented solutions dynamically segment, prioritize, and engage HCP and consumer audiences, delivering superior performance and script lift.  

Medical device and medtech brands need to maximize budget efficiency. We drive cost-effective HCP engagement and patient acquisition by finding your ideal audience, then increasing the relevance and actionability of your brand communications. 

Bring your brand strategies to life – and deliver incredible results for your clients. We make it easier for our agency partners to incorporate more precise audience targeting and omnichannel delivery into their marketing campaigns.  

 

Increase the effectiveness of your life science customers' brand marketing with custom-built, scalable, and clinically-specific consumer segments. Our privacy-safe technology delivers superior ad performance – and the competitive edge to grow advertising dollars.

 

Achieve a New Level of Precision and Impact from Consumer Marketing Programs 

Learn more about how data science and technology are driving performance and impact for direct-to-consumer marketing programs. 

patient-first-engagement-blog image

Navigating Patient-First Engagement in an Escalating Privacy-Conscious Era

Reaching Pharma Consumer with Hyperlocal Media Execution